combretastatin has been researched along with stilbenes in 92 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (2.17) | 18.7374 |
1990's | 14 (15.22) | 18.2507 |
2000's | 56 (60.87) | 29.6817 |
2010's | 16 (17.39) | 24.3611 |
2020's | 4 (4.35) | 2.80 |
Authors | Studies |
---|---|
Chu, PS; Getahun, Z; Hamel, E; Jurd, L; Lin, CM | 1 |
Chu, PS; Dempcy, RO; Hamel, E; Lin, CM; Pettit, GR; Schmidt, JM; Singh, SB | 1 |
Hamel, E; Lin, CM | 1 |
López, JL; Medarde, M; Peláez-Lamamié de Clairac, R; San Feliciano, A | 1 |
Kajiyama, S; Kobayashi, A | 1 |
Sackett, DL | 1 |
Chaplin, DJ; Hill, SA; Parkins, CS; Pettit, GR | 1 |
Day, BW; Hamel, E; Rosenkranz, HS; ter Haar, E | 1 |
Bianchi, L; Faravelli, L; Guatteo, E; Pelizzoni, F; Rogers, CB; Verotta, L; Wanke, E | 1 |
Bellini, B; Miglierini, G; Orsini, F; Pelizzoni, F | 1 |
Breidahl, T; Horsman, MR; Maxwell, RJ; Nielsen, FU; Stødkilde-Jørgensen, H | 1 |
Akiyama, Y; Fujita, K; Fukuda, Y; Hatanaka, T; Nakagawa, R; Nihei, Y; Ohsumi, K; Suga, Y; Tsuji, T | 1 |
Aleksandrzak, K; Hadfield, JA; McGown, AT | 1 |
Caballero, E; Feliciano, AS; Grávalos, DG; López, JL; Medarde, M; Peláez-Lamamié de Clairac, R; Ramos, AC | 1 |
Caballero, E; del Rey, B; Inchaustti, A; Medarde, M; Ramos, AC; Rojas de Arias, A; San Feliciano, A; Yaluff, G | 1 |
Couladouros, EA; Li, T; Moutsos, VI; Pitsinos, EN; Soufli, IC | 1 |
Randal, J | 1 |
Glass, TE; Johnson, RK; Kingston, DG; Mattern, MR; Schwikkard, S; Sharp, JL; Zhou, BN | 1 |
Brown, ML; Macdonald, TL; Rieger, JM | 1 |
Kovar, P; Ng, SC; Rosenberg, SH; Tahir, SK | 1 |
Chaudhuri, AR; Hausheer, FH; Ludueña, RF; Schwarz, PM; Seetharamalu, P | 1 |
Iwasaki, S; Shirai, R | 1 |
Bailly, C; Lansiaux, A; Verdier-Pinard, P | 1 |
Lodge, MA; Maxwell, RJ; Prise, VE; Rustin, GJ; Tozer, GM; Vojnovic, B; Wilson, J | 1 |
Bentzen, S; Galbraith, SM; Lodge, MA; Padhani, AR; Rustin, GJ; Stirling, JJ; Taylor, NJ | 1 |
Bane, SL; Janik, ME | 1 |
Hill, SA; Kanthou, C; Parkins, CS; Tozer, GM | 1 |
Ahn, BZ; Hong, DH; Kim, HM; Kim, Y; Nam, NH; You, YJ | 1 |
Chang, CW; Chang, JY; Chang, YY; Chen, TW; Chern, SS; Hsieh, HP; Lin, CH; Lin, YT; Liou, JP; Mahindroo, N; Tan, UK; Wang, CC; Yang, YN | 1 |
Lee, AE; McKeage, MJ; Pruijn, FB; Shalal-Zwain, S; Siim, BG; Wilson, WR | 1 |
Prinz, H | 1 |
Coy, DH; Fuselier, JA; Murphy, WA; Sun, L; Vasilevich, N; Woltering, SN | 1 |
Collins, JM | 1 |
Anderson, H; Folkes, LK; Galbraith, SM; Gumbrell, L; Price, PM; Rustin, GJ; Sena, L; Stratford, M | 1 |
Akita, H; Hori, K; Kawaguchi, T; Saito, S; Sato, H; Sato, Y; Sugiyama, K | 1 |
Gaukroger, K; Hadfield, JA; Lawrence, NJ; McGown, AT; Nolan, S | 1 |
Mariani, SM | 1 |
Cirla, A; Mann, J | 1 |
Anthoney, DA; Bibby, MC; Cooper, PA; Kirwan, IG; Lippert, JW; Loadman, PM; Pettit, GR; Shnyder, SD; Swaine, DJ | 1 |
Cavanaugh, SX; Hammond, LA; Thomas, CR | 1 |
Kiziltepe, T; Sasisekharan, R; Sengupta, S | 1 |
Ducki, S; Lawrence, NJ; Mackenzie, G; Snyder, JP | 1 |
Maya, AB; Medarde, M; Pérez-Melero, C | 1 |
Caballero, E; Medarde, M; Peláez, R; Pérez-Melero, C; Salvador, N; Sánchez Maya, AB | 1 |
Charoenchai, P; Danwisetkanjana, K; Intamas, S; Kittakoop, P; Thebtaranonth, Y; Vongvanich, N | 1 |
Bosmans, H; Chen, F; De Keyzer, F; Hermans, R; Landuyt, W; Marchal, G; Ni, Y; Thoeny, HC; Verbeken, EK | 1 |
Bentzen, L; Bjørnerud, A; Briley-Saebø, K; Horsman, MR; Nielsen, T; Ostergaard, L; Overgaard, J; Vestergaard-Poulsen, P | 1 |
Hsieh, HP; Liou, JP; Mahindroo, N | 1 |
Gaukroger, K; Hadfield, JA; Hirst, N; Lawrence, NJ; McGown, AT; Weston, AP | 1 |
Baguley, BC; Kanthou, C; Tozer, GM | 1 |
Allegrone, G; Coggiola, B; Genazzani, AA; Pagliai, F; Tron, GC | 1 |
Kiani, MF; Moore, BM; Nallamothu, R; Pattillo, CB; Sari-Sarraf, F; Wood, GC | 1 |
Mooney, D | 1 |
Capila, I; Eavarone, D; Kiziltepe, T; Sasisekharan, R; Sengupta, S; Watson, N; Zhao, G | 1 |
Arman, H; Brown, T; Dickson, J; Harris, J; Holt, HL; LeBlanc, R; Lee, M; Pati, HN; Pennington, W; Stewart, M; VanDerveer, D | 1 |
Erturk, SM | 1 |
Cousin, D; Mann, J; Nieuwenhuyzen, M; van den Berg, H | 1 |
Ackley, JF; Edvardsen, K; Garner, CM; Hadimani, MB; Monk, KA; Mugabe, BE; Pettit, GR; Pinney, KG; Rhodes, MR; Siles, R; Studerus, SW; Trawick, ML | 1 |
Alloatti, D; Baruchello, R; Bucci, F; Carminati, P; Castorina, M; Giannini, G; Guglielmi, MB; Marcellini, M; Pavani, MG; Pisano, C; Riccioni, T; Rizzi, M; Romagnoli, R; Rondanin, R; Simoni, D | 1 |
Beltrami, L; Busacca, S; Genazzani, AA; Imovilli, D; Massarotti, A; Miglio, G; Pagliai, F; Pirali, T; Sorba, G; Tron, GC; Verotta, L | 1 |
Martin, S | 1 |
Alvarez, C; Alvarez, R; Corchete, P; Medarde, M; Peláez, R; Pérez-Melero, C | 1 |
Bajenaru, ML; Feuer, W; Fini, ME; Jockovich, ME; Murray, TG; Piña, Y; Suarez, F | 1 |
López, V; Mateo, C; Medarde, M; Peláez, R | 1 |
Byung-Zun, A; Nam, NH | 1 |
Alvarez, R; Mateo, C; Medarde, M; Peláez, R; Pérez-Melero, C | 1 |
Stratford, MR | 1 |
Ackley, JF; Chaplin, DJ; Chapuis, JC; Edvardsen, K; Garner, CM; Guddneppanavar, R; Hadimani, MB; Hall, JJ; Monk, KA; Mugabe, BE; Pettit, GR; Pinney, KG; Siles, R; Trawick, ML | 1 |
Alloatti, D; Cabri, W; Carminati, P; Ciacci, A; Gallo, G; Giannini, G; Guglielmi, MB; Lustrati, I; Marcellini, M; Marzi, M; Pisano, C; Riccioni, T; Tinti, MO | 1 |
Burchill, SA; Dalal, S | 1 |
Chapuis, JC; Hamel, E; Hogan, F; Moser, BR; Pettit, GR; Pettit, RK; Pon, S; Schmidt, JM; Wolf, S | 1 |
Groy, TL; Herald, CL; Knight, JC; Melody, N; Pettit, GR; Thornhill, A | 1 |
Hogan, F; Minardi, MD; Pettit, GR; Price, PM | 1 |
Hua, R; Li, J; Liu, T | 1 |
Cai, YC; Xian, LJ; Zou, Y | 1 |
Babu, B; Brockway, O; Dandavati, A; Lee, M; Mooberry, SL; Satam, V; Sjoholm, R; Tzou, S; Westbrook, C; Zeller, M | 1 |
Babu, B; Bandi, RK; Behera, AK; Brockway, O; Lee, M; Mishra, BK; Mooberry, SL; Pati, H; Satam, V; Tzou, S; Westbrook, C; Zeller, M | 1 |
Bisby, RH; Botchway, SW; Hadfield, JA; McGown, AT; Parker, AW; Scherer, KM | 1 |
Azzariti, A; Gnoni, A; Numico, G; Paradiso, A; Porcelli, L; Quatrale, AE | 1 |
Chaplin, DJ; Garner, CM; Ghatak, A; Hadimani, MB; Hall, JJ; Hamel, E; Kessler, RJ; Liu, L; Lopez, R; Macdonough, MT; Mason, RP; Nguyen, BL; Pettit, GR; Pinney, KG; Shirali, AR; Sriram, M; Strecker, TE; Trawick, ML | 1 |
Chang, HZ; Huang, DP; Huang, TK; Jiang, XQ; Lai, SS; Tang, WJ; Wang, L; Wei, XH; Xu, XD; Yang, RM; Zou, Y | 1 |
Lipeeva, AV; Pokrovsky, AG; Pokrovsky, MA; Shakirov, MM; Shults, EE | 1 |
Álvarez, R; López, V; Mateo, C; Medarde, M; Peláez, R | 1 |
Jakubowska, J; Krawczyk, H; Książek, K; Mikuła-Pietrasik, J | 1 |
Bao, K; Guan, Q; Guo, D; Jiang, M; Liu, C; Wu, Y; Xu, J; Yang, F; Zhang, W | 1 |
Giacomini, E; Guidotti, L; Recanatini, M; Roberti, M; Rupiani, S | 1 |
Aoshima, K; Hoshino, Y; Izumi, Y; Takagi, S | 1 |
Bernasconi, L; Bisby, RH; Holzmann, N; Parker, AW | 1 |
Elming, PB; Horsman, MR; Nielsen, PS; Wittenborn, TR | 1 |
Kucinska, M; Murias, M; Pecyna, P; Wargula, J | 1 |
Kankala, RK; Kankala, S; Nerella, S; Paidakula, S | 1 |
Abourehab, MAS; Beshay, BY; Elbastawesy, MAI; Masoud, RE; Moustafa, AMY; Zakaria, MY; Zaki, I | 1 |
15 review(s) available for combretastatin and stilbenes
Article | Year |
---|---|
[Molecular basis of probes for cytoskeletal proteins].
Topics: Animals; Bibenzyls; Colchicine; Cytoskeletal Proteins; Fertilization; Microtubules; Mitosis; Paclitaxel; Sea Urchins; Stilbenes; Zearalenone | 1993 |
Podophyllotoxin, steganacin and combretastatin: natural products that bind at the colchicine site of tubulin.
Topics: 4-Butyrolactone; Animals; Antineoplastic Agents, Phytogenic; Bibenzyls; Binding Sites; Cell Division; Lignans; Podophyllotoxin; Polymers; Stilbenes; Structure-Activity Relationship; Tubulin | 1993 |
[Natural organic compounds that affect to microtubule functions: syntheses and structure-activity relationships of combretastatins, curacin A and their analogs as the colchicine-site ligands on tubulin].
Topics: Bibenzyls; Binding Sites; Cell Cycle; Colchicine; Cyclopropanes; Ligands; Microtubules; Protein Binding; Stilbenes; Structure-Activity Relationship; Thiazoles; Tubulin | 2000 |
[Combretastatin A4 phosphate].
Topics: Animals; Antineoplastic Agents, Phytogenic; Bibenzyls; Clinical Trials as Topic; Drug Evaluation, Preclinical; Humans; Mice; Neoplasms; Neovascularization, Pathologic; Quantitative Structure-Activity Relationship; Rats; Stilbenes; Transplantation, Heterologous | 2001 |
The biology of the combretastatins as tumour vascular targeting agents.
Topics: Animals; Antineoplastic Agents, Phytogenic; Bibenzyls; Endothelium, Vascular; Humans; Neoplasms; Neovascularization, Pathologic; Stilbenes | 2002 |
Recent advances in the field of tubulin polymerization inhibitors.
Topics: Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Bibenzyls; Biological Factors; Drug Design; Humans; Neoplasms; Protein Binding; Stilbenes; Tubulin; Tubulin Modulators | 2002 |
Combretastatins: from natural products to drug discovery.
Topics: Antineoplastic Agents, Phytogenic; Bibenzyls; Biological Products; Combretum; Molecular Structure; Plant Bark; South Africa; Stilbenes; Structure-Activity Relationship | 2003 |
Naphthalene combretastatin analogues: synthesis, cytotoxicity and antitubulin activity.
Topics: Animals; Bibenzyls; Cell Line, Tumor; Cell Survival; Drug Screening Assays, Antitumor; Humans; Molecular Structure; Naphthalenes; Stilbenes; Structure-Activity Relationship; Tubulin; Tubulin Modulators | 2004 |
Pharmaceutical design of antimitotic agents based on combretastatins.
Topics: Animals; Antineoplastic Agents; Bibenzyls; Clinical Trials as Topic; Drug Design; Humans; Stilbenes | 2005 |
Disrupting tumour blood vessels.
Topics: Angiogenesis Inhibitors; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Bibenzyls; Capillary Permeability; Clinical Trials as Topic; Endothelial Cells; Humans; Neoplasms; Neovascularization, Pathologic; Stilbenes; Xanthones | 2005 |
[Advances in the study of the anti-tumor activity of small molecule vascular disrupting agents].
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Bibenzyls; Diphosphates; Endothelial Cells; Humans; Molecular Structure; Neoplasms; Neovascularization, Pathologic; Oligopeptides; Organophosphorus Compounds; Serine; Stilbenes; Tubulin Modulators; Xanthones | 2010 |
New vascular disrupting agents in upper gastrointestinal malignancies.
Topics: Angiogenesis Inhibitors; Animals; Bibenzyls; Diphosphates; Gastrointestinal Neoplasms; Humans; Neovascularization, Pathologic; Organophosphorus Compounds; Serine; Stilbenes; Upper Gastrointestinal Tract | 2014 |
The Use of Stilbene Scaffold in Medicinal Chemistry and Multi- Target Drug Design.
Topics: Alzheimer Disease; Antineoplastic Agents, Phytogenic; Bibenzyls; Chemistry, Pharmaceutical; Drug Design; Humans; Neoplasms; Resveratrol; Stilbenes; Structure-Activity Relationship | 2016 |
More Than Resveratrol: New Insights into Stilbene-Based Compounds.
Topics: Animals; Bibenzyls; Drug Discovery; Humans; Resveratrol; Stilbenes | 2020 |
Recent Trends in Tubulin-Binding Combretastatin A-4 Analogs for Anticancer Drug Development.
Topics: Antineoplastic Agents; Bibenzyls; Cell Line, Tumor; Cell Proliferation; Drug Design; Humans; Neoplasms; Stilbenes; Structure-Activity Relationship; Tubulin; Tubulin Modulators | 2022 |
1 trial(s) available for combretastatin and stilbenes
Article | Year |
---|---|
Phase I clinical trial of weekly combretastatin A4 phosphate: clinical and pharmacokinetic results.
Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Area Under Curve; Bibenzyls; Chromatography, High Pressure Liquid; Drug Administration Schedule; Female; Humans; Infusion Pumps; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasms; Statistics, Nonparametric; Stilbenes; Tomography, Emission-Computed; Treatment Outcome | 2003 |
76 other study(ies) available for combretastatin and stilbenes
Article | Year |
---|---|
Synthesis of alkoxy-substituted diaryl compounds and correlation of ring separation with inhibition of tubulin polymerization: differential enhancement of inhibitory effects under suboptimal polymerization reaction conditions.
Topics: Animals; Antineoplastic Agents; Bibenzyls; Binding Sites; Bridged-Ring Compounds; Colchicine; Leukemia L1210; Mice; Stilbenes; Structure-Activity Relationship; Tubulin | 1992 |
Interactions of tubulin with potent natural and synthetic analogs of the antimitotic agent combretastatin: a structure-activity study.
Topics: Animals; Anisoles; Antineoplastic Agents; Bibenzyls; Binding Sites; Binding, Competitive; Colchicine; Leukemia L1210; Mice; Mitosis; Podophyllotoxin; Protein Binding; Stilbenes; Structure-Activity Relationship; Tubulin | 1988 |
Interactions of combretastatin, a new plant-derived antimitotic agent, with tubulin.
Topics: Animals; Anisoles; Bibenzyls; Binding Sites; Brain Chemistry; Cattle; Cells, Cultured; Colchicine; Leukemia L1210; Mice; Mitosis; Protein Binding; Stilbenes; Tubulin | 1983 |
A versatile approach to the synthesis of combretastatins.
Topics: Antineoplastic Agents, Phytogenic; Bibenzyls; Magnetic Resonance Spectroscopy; Spectrophotometry, Ultraviolet; Stilbenes | 1994 |
Antivascular approaches to solid tumour therapy: evaluation of tubulin binding agents.
Topics: Animals; Antineoplastic Agents; Bibenzyls; Depsipeptides; Flavonoids; Mice; Mice, Inbred CBA; Neoplasms, Experimental; Oligopeptides; Regional Blood Flow; Stilbenes; Tirapazamine; Triazines; Tubulin; Tumor Necrosis Factor-alpha; Vinblastine | 1996 |
Computational and molecular modeling evaluation of the structural basis for tubulin polymerization inhibition by colchicine site agents.
Topics: Antineoplastic Agents, Phytogenic; Bibenzyls; Binding Sites; Colchicine; Models, Molecular; Paclitaxel; Podophyllotoxin; Protein Conformation; Software; Stilbenes; Tubulin; Tubulin Modulators | 1996 |
A novel K+ channel blocker isolated from 'hiccup nut' toxin.
Topics: Animals; Antineoplastic Agents, Phytogenic; Bibenzyls; Dose-Response Relationship, Drug; Ganglia, Spinal; Humans; Potassium Channels; Rats; Stilbenes | 1996 |
Synthesis of biologically active polyphenolic glycosides (combretastatin and resveratrol series).
Topics: Antineoplastic Agents; Bibenzyls; Cell Division; Ganglia, Spinal; Glucosides; Glycosylation; Magnetic Resonance Spectroscopy; Mass Spectrometry; Mitosis; Molecular Structure; Platelet Aggregation Inhibitors; Resveratrol; Stilbenes; Tumor Cells, Cultured | 1997 |
Effects of combretastatin on murine tumours monitored by 31P MRS, 1H MRS and 1H MRI.
Topics: Animals; Antineoplastic Agents, Phytogenic; Bibenzyls; Drug Screening Assays, Antitumor; Energy Metabolism; Hydrogen; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Mammary Neoplasms, Animal; Mice; Necrosis; Phosphorus; Stilbenes | 1998 |
Novel B-ring modified combretastatin analogues: syntheses and antineoplastic activity.
Topics: Antineoplastic Agents, Phytogenic; Bibenzyls; Drug Stability; Humans; Stilbenes; Structure-Activity Relationship | 1998 |
Antimitotic activity of diaryl compounds with structural features resembling combretastatin A-4.
Topics: Animals; Antineoplastic Agents, Phytogenic; Bibenzyls; Drug Screening Assays, Antitumor; Leukemia P388; Mice; Stilbenes; Structure-Activity Relationship; Tumor Cells, Cultured | 1998 |
Synthesis and pharmacological activity of diarylindole derivatives. Cytotoxic agents based on combretastatins.
Topics: Antineoplastic Agents, Phytogenic; Bibenzyls; Drug Screening Assays, Antitumor; Humans; Stilbenes; Tumor Cells, Cultured | 1999 |
Leishmanicidal activity of combretastatin analogues and heteroanalogues.
Topics: Animals; Antiprotozoal Agents; Bibenzyls; Leishmania; Mice; Species Specificity; Stilbenes | 1999 |
Stabilization of microtubules by Combretastatin D derivatives.
Topics: Bibenzyls; Microtubules; Molecular Structure; Stilbenes | 1999 |
Antiangiogenesis drugs target specific cancers, mechanisms.
Topics: Angiostatins; Animals; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Bibenzyls; Humans; Matrix Metalloproteinase Inhibitors; Neoplasms; Neovascularization, Pathologic; Peptide Fragments; Plasminogen; Stilbenes | 2000 |
Bioactive compounds from Combretum erythrophyllum.
Topics: Antineoplastic Agents, Phytogenic; Bibenzyls; Carbohydrate Sequence; DNA Damage; DNA Repair; Drug Screening Assays, Antitumor; Glycosides; Humans; Magnetic Resonance Spectroscopy; Mass Spectrometry; Molecular Sequence Data; Plant Extracts; Plants, Medicinal; South Africa; Spectrophotometry, Ultraviolet; Stilbenes; Tumor Cells, Cultured; Wood | 2000 |
Comparative molecular field analysis of colchicine inhibition and tubulin polymerization for combretastatins binding to the colchicine binding site on beta-tubulin.
Topics: Bibenzyls; Binding Sites; Biopolymers; Colchicine; Molecular Conformation; Stilbenes; Tubulin | 2000 |
Rapid colchicine competition-binding scintillation proximity assay using biotin-labeled tubulin.
Topics: Aminophenols; Bibenzyls; Binding Sites; Binding, Competitive; Biotinylation; Colchicine; Demecolcine; Mebendazole; Microspheres; Podophyllotoxin; Scintillation Counting; Solvents; Stilbenes; Streptavidin; Sulfonamides; Tritium; Tubulin; Yttrium | 2000 |
The interaction of the B-ring of colchicine with alpha-tubulin: a novel footprinting approach.
Topics: Amino Acid Sequence; Animals; Bibenzyls; Binding Sites; Cattle; Chromatography, High Pressure Liquid; Colchicine; Fluorescence; Models, Molecular; Molecular Sequence Data; Peptide Fragments; Podophyllotoxin; Protein Conformation; Protein Footprinting; Stilbenes; Tropolone; Tryptophan; Tubulin; Urea | 2000 |
Evaluation of the anti-vascular effects of combretastatin in rodent tumours by dynamic contrast enhanced MRI.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents, Phytogenic; Antipyrine; Bibenzyls; Carcinosarcoma; Contrast Media; Gadolinium DTPA; Iodine Radioisotopes; Magnetic Resonance Imaging; Male; Radionuclide Imaging; Rats; Stilbenes | 2002 |
Reproducibility of dynamic contrast-enhanced MRI in human muscle and tumours: comparison of quantitative and semi-quantitative analysis.
Topics: Antineoplastic Agents; Bibenzyls; Contrast Media; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Muscle, Skeletal; Neoplasms; Reproducibility of Results; Stilbenes; Xanthenes; Xanthones | 2002 |
Synthesis and antimicrotubule activity of combretatropone derivatives.
Topics: Antineoplastic Agents; Bibenzyls; Colchicine; Magnetic Resonance Spectroscopy; Microtubules; Molecular Structure; Stilbenes; Structure-Activity Relationship; Tubulin; Tubulin Modulators | 2002 |
Synthesis and anti-tumor activity of novel combretastatins: combretocyclopentenones and related analogues.
Topics: Animals; Antineoplastic Agents; Bibenzyls; Carcinoma, Lewis Lung; Cyclopentanes; Drug Screening Assays, Antitumor; Humans; Inhibitory Concentration 50; Mice; Stereoisomerism; Stilbenes; Structure-Activity Relationship; Tumor Cells, Cultured | 2002 |
Structure-activity and crystallographic analysis of benzophenone derivatives-the potential anticancer agents.
Topics: Antineoplastic Agents; Benzophenones; Bibenzyls; Cell Cycle; Crystallography, X-Ray; Drug Resistance, Multiple; Drug Screening Assays, Antitumor; Humans; Inhibitory Concentration 50; Models, Molecular; Molecular Structure; Stilbenes; Structure-Activity Relationship; Tumor Cells, Cultured | 2003 |
Marked potentiation of the antitumour activity of chemotherapeutic drugs by the antivascular agent 5,6-dimethylxanthenone-4-acetic acid (DMXAA).
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bibenzyls; Carboplatin; Dose-Response Relationship, Drug; Drug Synergism; Female; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C3H; Paclitaxel; Stilbenes; Time Factors; Xanthenes; Xanthones | 2003 |
An adjustable release rate linking strategy for cytotoxin-peptide conjugates.
Topics: Amino Acid Sequence; Animals; Antineoplastic Agents; Bibenzyls; Camptothecin; Carbamates; Cross-Linking Reagents; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Inhibitory Concentration 50; Neuroblastoma; Peptides; Rats; Somatostatin; Stilbenes; Structure-Activity Relationship; Tumor Cells, Cultured | 2003 |
Functional imaging in phase I studies: decorations or decision making?
Topics: Animals; Antineoplastic Agents, Phytogenic; Bibenzyls; Clinical Trials, Phase I as Topic; Decision Making; Humans; Magnetic Resonance Imaging; Neoplasms; Rats; Stilbenes; Tomography, Emission-Computed | 2003 |
Differential relationship between changes in tumour size and microcirculatory functions induced by therapy with an antivascular drug and with cytotoxic drugs. implications for the evaluation of therapeutic efficacy of AC7700 (AVE8062).
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Bibenzyls; Blood Flow Velocity; Cell Division; Doxorubicin; Lung Neoplasms; Male; Microcirculation; Mitomycin; Neoplasm Transplantation; Rats; Stilbenes; Treatment Outcome | 2003 |
Structural requirements for the interaction of combretastatins with tubulin: how important is the trimethoxy unit?
Topics: Animals; Antineoplastic Agents; Bibenzyls; Cell Line; Chlorocebus aethiops; Drug Screening Assays, Antitumor; Humans; Immunohistochemistry; Inhibitory Concentration 50; K562 Cells; Molecular Structure; Stilbenes; Structure-Activity Relationship; Tubulin; Vero Cells | 2003 |
Anti-angiogenesis: the challenges ahead.
Topics: Angiogenesis Inhibitors; Angiogenic Proteins; Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Phytogenic; Bevacizumab; Bibenzyls; Biological Availability; Biomarkers; Carcinoma, Renal Cell; Clinical Trials as Topic; Combined Modality Therapy; Drug Resistance, Neoplasm; Endostatins; Endothelial Growth Factors; Endothelium, Vascular; Growth Inhibitors; Humans; Kidney Neoplasms; Microtubules; Neoplasms; Neovascularization, Pathologic; Ontario; Receptors, Vascular Endothelial Growth Factor; Stilbenes | 2003 |
Comparative preclinical pharmacokinetic and metabolic studies of the combretastatin prodrugs combretastatin A4 phosphate and A1 phosphate.
Topics: Animals; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Area Under Curve; Bibenzyls; Calibration; Cell Line, Tumor; Chromatography; Chromatography, High Pressure Liquid; Coloring Agents; Female; Humans; Inhibitory Concentration 50; Mass Spectrometry; Mice; Models, Chemical; Phosphorylation; Prodrugs; Stilbenes; Tetrazolium Salts; Thiazoles; Time Factors | 2004 |
An image worth a thousand lives?
Topics: Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Benzoquinones; Bibenzyls; Diagnostic Imaging; Down-Regulation; ErbB Receptors; Gefitinib; Heterocyclic Compounds, 1-Ring; HSP90 Heat-Shock Proteins; Humans; Lactams, Macrocyclic; Magnetic Resonance Imaging; Molecular Probe Techniques; Mutation; Neoplasms; Phthalazines; Physiological Phenomena; Positron-Emission Tomography; Protein Binding; Protein Kinase Inhibitors; Pyridines; Quinazolines; Receptor Protein-Tyrosine Kinases; Receptor, ErbB-2; Receptors, Vascular Endothelial Growth Factor; Rifabutin; Stilbenes; Tissue Distribution; Trastuzumab | 2004 |
A dual-color fluorescence imaging-based system for the dissection of antiangiogenic and chemotherapeutic activity of molecules.
Topics: Angiogenesis Inhibitors; Antineoplastic Agents; Bibenzyls; Cell Line, Tumor; Coculture Techniques; Doxorubicin; Extracellular Matrix; Fluorescence; Hepatocyte Growth Factor; Humans; Melanoma; Neoplasms; Neovascularization, Pathologic; Phthalazines; Pyridines; Stilbenes; Thalidomide; Vascular Endothelial Growth Factor A | 2004 |
Quantitative structure-activity relationship (5D-QSAR) study of combretastatin-like analogues as inhibitors of tubulin assembly.
Topics: Antineoplastic Agents; Bibenzyls; Binding Sites; Colchicine; Ligands; Models, Molecular; Molecular Conformation; Monte Carlo Method; Quantitative Structure-Activity Relationship; Stilbenes; Tubulin; Tubulin Modulators | 2005 |
New naphthylcombretastatins. Modifications on the ethylene bridge.
Topics: Animals; Bibenzyls; Cattle; Ethylenes; Inhibitory Concentration 50; Molecular Structure; Naphthalenes; Stilbenes; Structure-Activity Relationship; Tubulin | 2005 |
Combretastatins D-3 and D-4, new macrocyclic lactones from Getonia floribunda.
Topics: Antineoplastic Agents, Phytogenic; Antitubercular Agents; Bibenzyls; Cell Line, Tumor; Combretaceae; Humans; Inhibitory Concentration 50; Lactams, Macrocyclic; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Phytotherapy; Plant Extracts; Stilbenes | 2005 |
Diffusion-weighted MR imaging in monitoring the effect of a vascular targeting agent on rhabdomyosarcoma in rats.
Topics: Animals; Antineoplastic Agents, Phytogenic; Bibenzyls; Contrast Media; Diffusion Magnetic Resonance Imaging; Gadolinium DTPA; Image Processing, Computer-Assisted; Injections, Intraperitoneal; Male; Rats; Rhabdomyosarcoma; Stilbenes | 2005 |
Intravascular contrast agent-enhanced MRI measuring contrast clearance and tumor blood volume and the effects of vascular modifiers in an experimental tumor.
Topics: Animals; Antineoplastic Agents, Phytogenic; Bibenzyls; Contrast Media; Dextrans; Female; Ferrosoferric Oxide; Hydralazine; Iron; Magnetic Resonance Imaging; Magnetite Nanoparticles; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C3H; Oxides; Stilbenes; Vasodilator Agents | 2005 |
Synthesis and evaluation of double bond substituted combretastatins.
Topics: Amides; Antineoplastic Agents; Bibenzyls; Cell Cycle; Cell Survival; Epoxy Compounds; Formazans; Humans; Inhibitory Concentration 50; K562 Cells; Magnetic Resonance Spectroscopy; Molecular Structure; Spectrophotometry, Ultraviolet; Stilbenes; Tetrazolium Salts; Tubulin; Tubulin Modulators | 2005 |
Synthesis and biological activity of mustard derivatives of combretastatins.
Topics: Antineoplastic Agents; Bibenzyls; Humans; Inhibitory Concentration 50; Mustard Plant; Neuroblastoma; Nitrogen; Polymers; Stilbenes; Structure-Activity Relationship; Tubulin; Tubulin Modulators; Tumor Cells, Cultured | 2005 |
Targeting of the antivascular drug combretastatin to irradiated tumors results in tumor growth delay.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents, Phytogenic; Bibenzyls; Combined Modality Therapy; Drug Delivery Systems; Liposomes; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Neoplasm Transplantation; Stilbenes; Tumor Burden | 2005 |
Cancer: one step at a time.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Bibenzyls; Doxorubicin; Drug Delivery Systems; Drug Therapy, Combination; Humans; Mice; Nanotechnology; Neoplasms; Neovascularization, Pathologic; Stilbenes; Time Factors | 2005 |
Temporal targeting of tumour cells and neovasculature with a nanoscale delivery system.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Bibenzyls; Carcinoma, Lewis Lung; Coculture Techniques; Doxorubicin; Drug Delivery Systems; Drug Therapy, Combination; Endothelial Cells; Humans; Melanoma, Experimental; Mice; Nanotechnology; Neoplasms; Neovascularization, Pathologic; Stilbenes; Time Factors; Tissue Distribution | 2005 |
Synthesis and cytotoxicity of epoxide and pyrazole analogs of the combretastatins.
Topics: Animals; Bibenzyls; Cell Line; Crystallography, X-Ray; Epoxy Compounds; Mice; Molecular Structure; Pyrazoles; Stilbenes; Structure-Activity Relationship | 2005 |
Retrospective power analysis: when?
Topics: Animals; Antineoplastic Agents, Phytogenic; Bibenzyls; Contrast Media; Diffusion Magnetic Resonance Imaging; Gadolinium DTPA; Image Processing, Computer-Assisted; Injections, Intraperitoneal; Male; Rats; Rhabdomyosarcoma; Statistics as Topic; Stilbenes | 2005 |
A new approach to combretastatin D2.
Topics: Antineoplastic Agents; Bibenzyls; Boronic Acids; Breast Neoplasms; Cell Line; Cell Line, Tumor; Cell Proliferation; Colonic Neoplasms; Crystallography, X-Ray; Endothelial Cells; Female; Humans; Lactones; Magnetic Resonance Spectroscopy; Male; Molecular Structure; Phenol; Phenyl Ethers; Plants, Medicinal; Stilbenes | 2006 |
Design, synthesis, and biological evaluation of combretastatin nitrogen-containing derivatives as inhibitors of tubulin assembly and vascular disrupting agents.
Topics: Animals; Benzaldehydes; Bibenzyls; Cattle; Cell Proliferation; Drug Design; Isomerism; Mice; Molecular Structure; Neoplasms; Regional Blood Flow; Stilbenes; Structure-Activity Relationship; Tubulin; Xenograft Model Antitumor Assays | 2006 |
Novel combretastatin analogues endowed with antitumor activity.
Topics: Animals; Antineoplastic Agents; Benzofurans; Bibenzyls; Binding, Competitive; Biopolymers; Cell Line, Tumor; Cell Nucleus; Colchicine; Endothelial Cells; Endothelium, Vascular; Female; Humans; Mice; Mice, Nude; Microtubules; Organophosphates; Prodrugs; Stereoisomerism; Stilbenes; Structure-Activity Relationship; Thiophenes; Tubulin; Xenograft Model Antitumor Assays | 2006 |
Synthesis and cytotoxic evaluation of combretafurans, potential scaffolds for dual-action antitumoral agents.
Topics: Anisoles; Antineoplastic Agents; Bibenzyls; Cell Death; Cell Line, Tumor; Drug Screening Assays, Antitumor; Furans; Humans; Molecular Structure; Neuroblastoma; Stilbenes; Structure-Activity Relationship; Tubulin | 2006 |
New Agents in Clinical Oncology. 24 November 2006, London, UK.
Topics: 3-Iodobenzylguanidine; Animals; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Bibenzyls; Combined Modality Therapy; Enzyme Inhibitors; Humans; Medical Oncology; Neoplasms; Norepinephrine Plasma Membrane Transport Proteins; Poly(ADP-ribose) Polymerase Inhibitors; Proteomics; Stilbenes; Thioredoxins; Topotecan | 2007 |
Synthesis and biological activity of naphthalene analogues of phenstatins: naphthylphenstatins.
Topics: Antineoplastic Agents; Bibenzyls; HeLa Cells; Humans; Inhibitory Concentration 50; Models, Chemical; Naphthalenes; Stereoisomerism; Stilbenes; Structure-Activity Relationship; Tubulin; Tubulin Modulators; Tumor Cells, Cultured | 2007 |
Retinoblastoma tumor vessel maturation impacts efficacy of vessel targeting in the LH(BETA)T(AG) mouse model.
Topics: Actins; Angiogenesis Inhibitors; Animals; Antineoplastic Agents, Phytogenic; Bibenzyls; Biomarkers, Tumor; Cell Proliferation; Disease Models, Animal; Endoglin; Endothelium, Vascular; Intracellular Signaling Peptides and Proteins; Ki-67 Antigen; Mice; Mice, Transgenic; Microscopy, Fluorescence; Neovascularization, Pathologic; Pericytes; Pregnadienediols; Retinal Neoplasms; Retinoblastoma; Stilbenes | 2007 |
Synthesis and conformational analysis of macrocyclic dihydroxystilbenes linked between the para-para positions.
Topics: Antineoplastic Agents; Bibenzyls; Magnetic Resonance Spectroscopy; Models, Molecular; Molecular Conformation; Molecular Structure; Stereoisomerism; Stilbenes; Structure-Activity Relationship | 2007 |
Combretastatin-chalcone hybrids: synthesis and cytotoxicity.
Topics: Bibenzyls; Cell Line; Cell Survival; Chalcone; Humans; Molecular Structure; Neoplasms; Stilbenes; Structure-Activity Relationship | 2007 |
Conformationally restricted macrocyclic analogues of combretastatins.
Topics: Bibenzyls; Macrocyclic Compounds; Models, Molecular; Molecular Conformation; Stilbenes; Structure-Activity Relationship; Tubulin; Tubulin Modulators | 2007 |
Enhanced fluorescence detection of cis-combretastatins by post-column photolysis.
Topics: Bibenzyls; Chromatography, High Pressure Liquid; Photolysis; Spectrometry, Fluorescence; Stilbenes | 2008 |
Combretastatin dinitrogen-substituted stilbene analogues as tubulin-binding and vascular-disrupting agents.
Topics: Animals; Antineoplastic Agents; Bibenzyls; Disease Models, Animal; Drug Design; Drug Screening Assays, Antitumor; Humans; Inhibitory Concentration 50; Leukemia P388; Mice; Molecular Structure; Neoplasms; Regional Blood Flow; Stilbenes; Tubulin | 2008 |
Synthesis and biological activity of fluorinated combretastatin analogues.
Topics: Animals; Antineoplastic Agents; Bibenzyls; Biopolymers; Cattle; Cell Line, Tumor; Cells, Cultured; Crystallography, X-Ray; Drug Screening Assays, Antitumor; Endothelial Cells; Fluorine; Humans; Microcirculation; Microtubules; Stereoisomerism; Stilbenes; Structure-Activity Relationship; Tubulin | 2008 |
Preclinical evaluation of vascular-disrupting agents in Ewing's sarcoma family of tumours.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Bibenzyls; Bone Neoplasms; Cell Proliferation; Diphosphates; Disease Models, Animal; Doxorubicin; Drug Evaluation, Preclinical; Mice; Mice, Nude; Necrosis; Neoplasm Transplantation; Neovascularization, Pathologic; Sarcoma, Ewing; Stilbenes | 2009 |
E-Combretastatin and E-resveratrol structural modifications: antimicrobial and cancer cell growth inhibitory beta-E-nitrostyrenes.
Topics: Anti-Infective Agents; Antineoplastic Agents; Bacteria; Bibenzyls; Cell Line, Tumor; Cell Proliferation; Fungi; Humans; Molecular Structure; Resveratrol; Stilbenes; Structure-Activity Relationship; Styrenes; Tubulin; Tubulin Modulators | 2009 |
Antineoplastic agents. 579. Synthesis and cancer cell growth evaluation of E-stilstatin 3: a resveratrol structural modification.
Topics: Antineoplastic Agents; Bibenzyls; Crystallography, X-Ray; Drug Screening Assays, Antitumor; Humans; Molecular Conformation; Molecular Structure; Prodrugs; Resveratrol; Stereoisomerism; Stilbenes; Structure-Activity Relationship | 2009 |
An efficient synthetic strategy for obtaining 4-methoxy carbon isotope labeled combretastatin A-4 phosphate and other Z-combretastatins.
Topics: Bibenzyls; Isotope Labeling; Molecular Structure; Positron-Emission Tomography; Stereoisomerism; Stilbenes | 2010 |
Highly chemo- and stereoselective palladium-catalyzed transfer semihydrogenation of internal alkynes affording cis-alkenes.
Topics: Alkenes; Alkynes; Bibenzyls; Catalysis; Dimethylformamide; Hydrogen; Hydrogenation; Hydroxides; Molecular Structure; Palladium; Potassium Compounds; Stereoisomerism; Stilbenes | 2010 |
A novel class of trans-methylpyrazoline analogs of combretastatins: synthesis and in-vitro biological testing.
Topics: Animals; Antineoplastic Agents, Phytogenic; Bibenzyls; Cell Line, Tumor; Cell Survival; Crystallography, X-Ray; Drug Screening Assays, Antitumor; Humans; Inhibitory Concentration 50; Leukemia L1210; Melanoma, Experimental; Mice; Microtubules; Molecular Docking Simulation; Pyrazoles; Stilbenes; Structure-Activity Relationship; Tubulin Modulators | 2011 |
Design, synthesis, and cytotoxicity of novel 3-arylidenones derived from alicyclic ketones.
Topics: Animals; Antineoplastic Agents; Bibenzyls; Cell Line, Tumor; Cell Survival; Chalcones; Drug Design; Humans; Ketones; Mice; Models, Molecular; Neoplasms; Stilbenes; Structure-Activity Relationship; Tubulin Modulators | 2011 |
Fluorescence lifetime imaging of E-combretastatin uptake and distribution in live mammalian cells.
Topics: Animals; Bibenzyls; CHO Cells; Cricetinae; HeLa Cells; Humans; Microscopy, Fluorescence, Multiphoton; Stilbenes | 2012 |
Synthesis of a 2-aryl-3-aroyl indole salt (OXi8007) resembling combretastatin A-4 with application as a vascular disrupting agent.
Topics: Animals; Antineoplastic Agents; Bibenzyls; Colchicine; Drug Screening Assays, Antitumor; Humans; Indoles; Inhibitory Concentration 50; Male; Mice; Molecular Structure; Organophosphates; Prodrugs; Prostatic Neoplasms; Stilbenes; Structure-Activity Relationship; Tubulin | 2013 |
In vivo assessment of the vascular disrupting effect of M410 by DCE-MRI biomarker in a rabbit model of liver tumor.
Topics: Angiogenesis Inhibitors; Animals; Bibenzyls; Biomarkers, Tumor; Cell Line, Tumor; Liver Neoplasms, Experimental; Magnetic Resonance Imaging; Male; Organophosphates; Rabbits; Stilbenes | 2014 |
Synthesis and cytotoxic activity of a new group of heterocyclic analogues of the combretastatins.
Topics: Antineoplastic Agents, Phytogenic; Bibenzyls; Cell Line, Tumor; Coumarins; Drug Screening Assays, Antitumor; Ficusin; Furocoumarins; Humans; Molecular Structure; Neoplasms; Stilbenes; Structure-Activity Relationship; Tubulin Modulators | 2014 |
p,p-Dihydroxydihydrostilbenophanes related to antimitotic combretastatins. Conformational analysis and its relationship to tubulin inhibition.
Topics: Antimitotic Agents; Bibenzyls; Colchicine; Macrocyclic Compounds; Magnetic Resonance Spectroscopy; Models, Molecular; Molecular Conformation; Polymerization; Stilbenes; Tubulin Modulators | 2014 |
Cytotoxicity studies of novel combretastatin and pterostilbene derivatives.
Topics: Bibenzyls; Cell Death; Cell Line, Tumor; Cell Proliferation; Drug Screening Assays, Antitumor; Humans; Resveratrol; Stilbenes | 2014 |
Synthesis and biological evaluation of novel 3,4-diaryl-1,2,5-selenadiazol analogues of combretastatin A-4.
Topics: Antineoplastic Agents, Phytogenic; Bibenzyls; Cell Cycle; Cell Proliferation; Drug Screening Assays, Antitumor; Flow Cytometry; Fluorescent Antibody Technique; Heterocyclic Compounds; Humans; Models, Molecular; Molecular Structure; Neoplasms; Selenium; Stilbenes; Structure-Activity Relationship; Tumor Cells, Cultured | 2014 |
Effects of combretastatin A-4 phosphate on canine normal and tumor tissue-derived endothelial cells.
Topics: Animals; Bibenzyls; Cells, Cultured; Dogs; Endothelial Cells; Endothelium, Vascular; Humans; Neoplasms; Neovascularization, Pathologic; Phosphates; Stilbenes | 2017 |
Influence of charge transfer on the isomerisation of stilbene derivatives for application in cancer therapy.
Topics: Antineoplastic Agents; Bibenzyls; Humans; Isomerism; Light; Models, Molecular; Molecular Structure; Neoplasms; Photochemical Processes; Stilbenes; Structure-Activity Relationship; Thermodynamics | 2018 |
Tumors Resistant to Checkpoint Inhibitors Can Become Sensitive after Treatment with Vascular Disrupting Agents.
Topics: Animals; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; B7-H1 Antigen; Bibenzyls; CTLA-4 Antigen; Diphosphates; Disease Progression; Drug Resistance, Neoplasm; Female; Immune Checkpoint Inhibitors; Male; Mammary Neoplasms, Animal; Mice; Mice, Inbred C3H; Neovascularization, Pathologic; Stilbenes; Treatment Outcome | 2020 |
Design and synthesis of new trimethoxylphenyl-linked combretastatin analogues loaded on diamond nanoparticles as a panel for ameliorated solubility and antiproliferative activity.
Topics: Amides; Antineoplastic Agents; Bibenzyls; Cell Line, Tumor; Cell Proliferation; Drug Screening Assays, Antitumor; Molecular Structure; Nanoparticles; Solubility; Stilbenes; Structure-Activity Relationship; Tubulin; Tubulin Modulators | 2022 |